Flexion Therapeutics Inc

Flexion Therapeutics Inc

FLXN

Market Cap$0
Close$

Compare to Similar Companies

P/E RatioDividendsReturn on EquityPrice-to-SalesDebt-to-Equity
Flexion Therapeutics IncFlexion Therapeutics Inc-3.4-122%9.1-3
$11.64

Current Fair Value

27.6% upside

Undervalued by 27.6% based on the discounted cash flow analysis.

Share Statistics

Market cap$0.00
Enterprise Value$108.45 Million
Dividend Yield$0 (0%)
Earnings per Share$-2.66
Beta1.53
Outstanding Shares50,265,000

Return

Return on Equity-
Return on Assets-
Return on Invested Capital-

Valuation & Multiples

P/E Ratio-3.43
PEG-14.9
Price to Sales9.12
Price to Book Ratio-4.56
Enterprise Value to Revenue1.08
Enterprise Value to EBIT-1.38
Enterprise Value to Net Income-2
Total Debt to Enterprise2.31
Debt to Equity-3.04

Revenue Sources

No data

Insider Trades

ESG Score

No data

About Flexion Therapeutics Inc

CEO: Michael Clayman